Mercalis in Motion
Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace to accelerate value and enhance patient lives. Founded in 2000, Mercalis provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina. For more information about Mercalis, please visit www.mercalis.com.
Episodes
35 episodes
Mercalis Celebrates National Nurses Week 2025
To commemorate National Nurses Week 2025, Landy and Eric welcome our colleague Heather Smith, PhD, RN, NNP to the studio to discuss Mercalis’s burgeoning suite of nursing services that focus on patient care and education. Over the past sever...
Optimizing HCP Engagement: Strategies for Every Stage of the Product Life Cycle
In this episode of Mercalis in Motion, Landy and Eric welcome to the studio two members of the Mercalis HCP Engagement Team: VP of HCP Engagement Operations Nolan Watts, and Business Development Manager John Katter. Please join us for an inform...
Mercalis Executive Leadership Reflects on 2024 Successes and Future Strategy
Landy and Eric are joined in the studio by Mercalis President and Chief Commercial Officer Joe Abdalla and Mercalis Chief Strategy Officer and Head of Data & Insights Chris Apolito. In this episode, Joe and Chris reflect upon Mercalis's suc...
Lessons on Employee Engagement, Culture, and Inclusivity in the Post-Pandemic Workplace
In this episode, Latrinda Williams, Mercalis's Senior Director of Employee Engagement and Culture joins Landy and Eric in studio to discuss her role within the growing Mercalis organization. Tune in to learn more about the lessons learned from ...
2024 in Review: Noteworthy Guests and Key Discussions
In this episode, our hosts Landy Townsend, VP of Marketing and Communications, and Eric Manning, Creative Director, take a look back at our 2024 episodes, highlighting notable guests and discussions from the past twelve months. We hope you enjo...
Biosimilars and their Impact on Pharma Patient Support Services
Our Thanksgiving episode of Mercalis in Motion is now available! In this episode, Mercalis team members Michael Turner, Terry Cato, and Blake Johnson join us to discuss the impact the introduction of biosimilars has made on the pharmac...
Mercalis Celebrates 15 Years of RxStudy Card
On this episode of Mercalis in Motion, Sean Boyler, Tom Gottschalk, and Robbie Hill join us in the studio to commemorate the 15-year anniversary of RxStudy Card. What follows is a conversation about how RxStudy Card by Mercalis has evolve...
Simplifying eServices with Mercalis’s Curator Solution
Today, Landy and Eric welcome three members of the Mercalis Products Team to the studio. Bill Dupere, Stephanie Chesebro, and Nick Hill stopped by to discuss recent developments related to the Mercalis eServices and Curator capabilities.&...
The Mercalis Nurse Network
In this episode, Heather Smith, PhD, RN, NNP visits the studio to discuss the Mercalis Nurse Network. For the past seven years, Mercalis has provided its clients and their patients with a growing suite of services focused on patient care ...
Market Trends, AI Strategy, and More: A Conversation With Policy Reporter by Mercalis
In this episode, Landy and Eric sit down with Jason Zemcik, Andrea Xu, and Bethany Najer of Policy Reporter by Mercalis to dive into a number of issues that are facing the life sciences market, as well as an update on Policy Reporter's offering...
Triangle Insights Group by Mercalis: A Discussion About the Inflation Reduction Act
Today on Mercalis in Motion, we’re pleased to share an episode featuring our colleagues from Triangle Insights Group by Mercalis. Triangle Insights Group, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guida...
Mercalis Commemorates Rare Disease Day 2024
Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. Rare Disease Day typically...
A Conversation With Mercalis CEO Scott Dulitz
Mercalis CEO Scott Dulitz joins Landy and Eric for Mercalis in Motion’s first podcast episode of 2024. Scott reflects on a very eventful and successful 2023 as well as what lies ahead for the life sciences commercialization partner in ...
2023 in Review: Noteworthy Guests and Key Discussions
In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluf...
Copay Accumulator Plan Designs: What Life Sciences Manufacturers Need to Know Heading into 2024
Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After sever...
TrialCard is now Mercalis!
In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis. Scott discusses the reasons that led to the rebrandin...
Navigating Alternate Funding Programs
Diana Villanova, TrialCard’s VP of Patient Support Services Strategy, joins Landy and Eric on today’s episode, to discuss Alternate Funding Programs (AFPs). Designed to limit plan sponsors’ financial exposure, the increased use of AFPs ha...
The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know
The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market a...
TrialCard's Non-Commercial Dispensing Pharmacy
In this episode of TrialCard TALK, we welcome to the studio Chris Harris, TrialCard's Vice President of Operations, to discuss the growth and impact that TrialCard's non-commercial dispensing pharmacy has had on the organization and its clients...
A Conversation with Dean Erhardt, president & CEO of D2 Solutions
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Dean Erhardt, President & CEO of D2 Solutions. D2 is a healthcare solutions company that leverages consulting expertise with SaaS-based technology tools to drive ...
TrialCard CEO Scott Dulitz
TrialCard CEO Scott Dulitz joins Landy and Eric on the first podcast of 2023 to reflect upon TrialCard’s success in 2022 and look ahead at some of the trends in the market that will define 2023.
Best of 2022 - TrialCard TALK
In the final episode of TrialCard TALK for 2022, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Associate Creative Director, reflect on the guests we have featured during the year and some of the hig...
Simplifying eServices with TrialCard’s Orchestrator solution
In the latest episode of TrialCard TALK, we speak to Bill Dupere, VP for Product Development for Patient Services, and Stephanie Chesebro, Product Owner – eServices on our IT Development Team, about TrialCard’s eServices and ‘Orchestrator’ solu...
Policy Reporter: Demystifying Payer Coverage To Serve Patients
In this episode of TrialCard TALK, we are joined by Tim Ogren, General Manager, and Peter Weissberg, Managing Director, at Policy Reporter – a TrialCard Company. Tim and Peter speak to us about the difference that the company makes to its clien...
Creating a More Efficient Clinical Supply Process with TrialCard’s RxStudy Card
In this episode of TrialCard TALK, Tom Gottschalk, Senior Director of Business Development for TrialCard, outlines how we support biotech and pharmaceutical companies’ clinical trial supply needs through our RxStudy Card™ – an innovative produc...